Anteris Technologies Global (NASDAQ:AVR) Stock: Insider L1 Capital Pty Ltd Acquires 648,455 Shares

Anteris Technologies Global Corp. (NASDAQ:AVR) major shareholder L1 Capital Pty Ltd acquired 648,455 shares of the stock in a transaction on Monday, October 5th. The stock was bought at an average cost of $7.51 per share, with a total value of $4,869,897.05. Following the completion of the transaction, the insider owned 12,778,380 shares in the company, valued at $95,965,633.80. This trade represents a 5.35% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

• On Friday, October 2nd, L1 Capital Pty Ltd bought 236,354 shares of Anteris Technologies Global stock. The shares were bought at an average cost of $7.78 per share, for a total transaction of $1,838,834.12.
• On Thursday, October 1st, L1 Capital Pty Ltd purchased 322,940 shares of Anteris Technologies Global stock. The shares were bought at an average cost of $7.60 per share, with a total value of $2,454,344.00.
• On Wednesday, September 30th, L1 Capital Pty Ltd purchased 74,286 shares of Anteris Technologies Global stock. The shares were bought at an average cost of $7.72 per share, with a total value of $573,487.92.
• On Friday, August 28th, L1 Capital Pty Ltd sold 7,800 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.83, for a total value of $68,874.00.
• On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The stock was sold at an average price of $9.30, for a total value of $3,495,079.50.
• On Monday, August 10th, L1 Capital Pty Ltd sold 251,844 shares of Anteris Technologies Global stock. The stock was sold at an average price of $9.10, for a total value of $2,291,780.40.
• On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total value of $1,415,240.10.
• On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.30, for a total value of $3,989,046.40.
• On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.23, for a total value of $120,001.63.
• On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total value of $3,853,113.30.

Anteris Technologies Global Trading Down 3.3%

AVR opened at $6.82 on Thursday. Anteris Technologies Global Corp. has a 12-month low of $3.30 and a 12-month high of $11.06. The business’s fifty day simple moving average is $8.44 and its 200-day simple moving average is $8.02. The company has a market capitalization of $664.68 million, a price-to-earnings ratio of -3.50 and a beta of 1.87.

Anteris Technologies Global (NASDAQ:AVR) last announced its quarterly earnings results on Tuesday, August 11th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.09). Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 77.69%. The firm had revenue of $1.01 million for the quarter, compared to analysts’ expectations of $1.50 million. During the same quarter in the prior year, the business posted ($0.58) EPS. On average, equities research analysts predict that Anteris Technologies Global Corp. will post -1.21 EPS for the current year.

Hedge Funds Weigh In On Anteris Technologies Global

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new stake in shares of Anteris Technologies Global during the second quarter valued at about $56,846,000. Nantahala Capital Management LLC purchased a new position in shares of Anteris Technologies Global in the 2nd quarter worth approximately $33,325,850. ADAR1 Capital Management LLC bought a new position in shares of Anteris Technologies Global during the 2nd quarter worth approximately $30,979,000. Perceptive Advisors LLC raised its stake in shares of Anteris Technologies Global by 104.4% during the 1st quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company’s stock worth $19,011,000 after acquiring an additional 1,750,000 shares in the last quarter. Finally, Assenagon Asset Management S.A. bought a new position in shares of Anteris Technologies Global during the 2nd quarter worth approximately $6,350,000.

Key Headlines Impacting Anteris Technologies Global

Here are the key news stories impacting Anteris Technologies Global this week:

• Positive Sentiment: Major shareholder made substantial purchases. L1 Capital Pty Ltd bought 648,455 AVR shares on October 5 at an average of $7.51, worth approximately $4.87 million, increasing its position by 5.35% to 12.78 million shares. The investor also purchased 236,354 shares on October 2 for about $1.84 million. The buying may bolster confidence because a large shareholder is committing additional capital while the stock is trading below recent moving averages. AVR insider buying report
• Neutral Sentiment: Share and incentive records were updated. Anteris reported a slight decrease in CHESS Depositary Interests and the lapse or cessation of several restricted stock unit and option tranches. These changes could affect the share count and potential dilution, but no new operating, clinical, or regulatory catalyst was announced. AVR CDI and equity incentive update
• Negative Sentiment: Financial performance remains weak. Anteris’ latest quarterly loss of $0.30 per share was wider than the $0.21 consensus estimate, while revenue of $1.01 million trailed expectations of $1.50 million. The clinical-stage structural-heart company remains unprofitable, with analysts expecting a full-year loss, factors that continue to weigh on valuation and investor sentiment. AVR earnings and performance report

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Wednesday, August 26th. Cantor Fitzgerald reiterated an “overweight” rating and set a $15.00 price objective on shares of Anteris Technologies Global in a research note on Friday, August 14th. Finally, Barclays started coverage on shares of Anteris Technologies Global in a report on Tuesday. They set an “equal weight” rating and a $10.00 price objective on the stock. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Anteris Technologies Global currently has a consensus rating of “Hold” and an average target price of $14.00.

About Anteris Technologies Global

Anteris Technologies Global is a clinical-stage structural heart company developing technologies intended to treat aortic valve disease. The company’s lead product is the DurAVR transcatheter heart valve, which is designed to replicate the performance characteristics of a healthy human aortic valve and restore more natural blood flow.

Anteris uses its proprietary ADAPT tissue-engineering technology to create heart-valve materials designed for durability and biocompatibility. The company is focused primarily on transcatheter aortic valve replacement and related structural-heart applications, with its products progressing through clinical development and regulatory evaluation rather than broad commercial distribution.

The company has Australian origins and maintains operations and clinical-development activities in both Australia and the United States.